Supplementary Materials and Methods; Supplementary Figures S1-S5; and Supplementary Tables S1-S5 from α<sub>V</sub>β<sub>3</sub> Integrin-Targeted Radionuclide Therapy with <sup>64</sup>Cu-cyclam-RAFT-c(-RGDfK-)<sub>4</sub>